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VDAC1 over-expressionVDAC1, an outermitochondrial membrane (OMM) protein, is crucial for regulatingmitochondrial metabolic and
energetic functions and acts as a convergence point for various cell survival and death signals. VDAC1 is also a key
player in apoptosis, involved in cytochrome c (Cyto c) release and interactions with anti-apoptotic proteins. Re-
cently, we demonstrated that various pro-apoptotic agents induce VDAC1 oligomerization and proposed that a
channel formed by VDAC1 oligomers mediates cytochrome c release. As VDAC1 transports Ca2+ across the
OMM and because Ca2+ has been implicated in apoptosis induction, we addressed the relationship between cy-
tosolic Ca2+ levels ([Ca2+]i), VDAC1 oligomerization and apoptosis induction. We demonstrate that different
apoptosis inducers elevate cytosolic Ca2+ and induce VDAC1 over-expression. Direct elevation of [Ca2+]i by
the Ca2+-mobilizing agents A23187, ionomycin and thapsigargin also resulted in VDAC1 over-expression,
VDAC1 oligomerization and apoptosis. In contrast, decreasing [Ca2+]i using the cell-permeable Ca2+-chelating
reagent BAPTA-AM inhibited VDAC1 over-expression, VDAC1 oligomerization and apoptosis. Correlation
between the increase in VDAC1 levels and oligomerization, [Ca2+]i levels and apoptosis induction, as induced
by H2O2 or As2O3, was also obtained. On the other hand, cells transfected to overexpress VDAC1 presented
Ca2+-independent VDAC1 oligomerization, cytochrome c release and apoptosis, suggesting that [Ca2+]i eleva-
tion is not a pre-requisite for apoptosis induction when VDAC1 is over-expressed. The results suggest that
Ca2+ promotes VDAC1 over-expression by an as yet unknown signaling pathway, leading to VDAC1 oligomeriza-
tion, ultimately resulting in apoptosis. These ﬁndings provide a new insight into the mechanism of action of
existing anti-cancer drugs involving induction of VDAC1 over-expression as amechanism for inducing apoptosis.
This article is part of a Special Issue entitled: Calcium Signaling in Health and Disease. Guest Editors: Geert
Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Various studies have demonstrated that components of Ca2+ signaling
pathways are remodeled or de-regulated in cancer so as to support
cancer cell proliferation and survival [1]. Furthermore, accumulated ev-
idence has demonstrated the importance of intracellular Ca2+ ([Ca2+]i)
in both the activation and the execution of cell death [2,3]. Indeed,
several studies have shown that Ca2+ is a mediator of cell death signal-
ing and that different pro-apoptotic agents, such as thapsigargin,
staurosporin, selenite, cisplatin, as well as Ca2+ ionophores, induce
apoptotic cell death by interfering with Ca2+ homeostasis [4]. [Ca2+]iycol bis[succinimidylsuccinate];
pendent anion channel
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tz).increases have been observed in the apoptotic cell and have been
shown to be required for apoptosis to even occur [5–7].
In addition to free cytoplasmic Ca2+, mitochondrial Ca2+ has also
been implicated in apoptosis induction [8]. Indeed, mitochondria are a
major hub of cellular Ca2+ homeostasis, controlling energymetabolism,
oxidative phosphorylation, secretion and cell death [9,10]. Ca2+
transport across the mitochondria requires negotiating both the outer
mitochondrial membrane (OMM) and the inner mitochondrial
membrane (IMM). Ca2+ transport across the IMM is mediated by the
Ca2+ uniporter protein (MCU), catalyzing the uptake of Ca2+, while
the Na+/Ca2+ exchanger is considered the major agent of Ca2+ efﬂux
[11–14]. At the OMM, Ca2+ transport is mediated by the voltage-
dependent anion channel 1 (VDAC1) [15–17]. VDAC1 also possesses
Ca2+-binding sites, allowing it to function as the Ca2+-sensitive barrier
of the OMM [15,18–21]. VDAC1, moreover, provides the main interface
between the mitochondria and the cytosol and plays a critical role in
apoptosis [22,23] through its function in the release of apoptotic
proteins located in the inter-membrane space (IMS) [24–26] and via
its interaction with the anti-apoptotic proteins Bcl-2, Bcl-xL [27–30]
and hexokinase (HK) [31–34].
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in a dynamic equilibrium between monomers and oligomers [35–39].
We proposed that upon apoptosis induction, VDAC1 oligomerizes to
form a large ﬂexible pore that allows Cyto c to cross the OMM [24,27,
37,39,40]. This concept has gained experimental support with the dem-
onstration that apoptosis induction in cultured cells leads to an up to
20-fold increase in VDAC1 oligomerization, as revealed by chemical
cross-linking and Bioluminescence Resonance Energy Transfer (BRET) as-
says [37]. Apoptosis-mediated increase in VDAC1 oligomerization was
observed regardless of the cell type or apoptosis inducer employed, in-
cluding STS, curcumin, arsenic trioxide, etoposide, cisplatin, selenite,
TNF-α, hydrogen peroxide, and UV light, all affecting mitochondria yet
acting via different mechanisms. Conversely, the apoptosis inhibitor
4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) prevented STS-
induced VDAC1 oligomerization and apoptosis [25,37].
At the same time, several studies demonstrated an increase in
VDAC1 expression levels following apoptosis induction. For example,
up-regulation of VDAC1 expression was observed in acute lymphoblas-
tic leukemia cell lines following prednisolone treatment [41] and in
cisplatin-sensitive cervix squamous carcinoma cells exposed to cisplat-
in, while in a cisplatin-resistant cell line, such treatment resulted in
down-regulation of VDAC1 [42]. Furthermore, in human malignant
melanoma cells, arbutin (hydroquinone-O-beta-D-glucopyranoside), a
tyrosinase inhibitor and a potential anti-cancer agent, was found to
induce apoptosis by causing VDAC1 over-expression [43,44]. Somato-
statin, reported to be useful in the treatment of advanced prostate
cancer, was found to up-regulate the expression of VDAC1 and VDAC2
in the LNCaP prostate cancer cell line [45]. In addition, both UV irradia-
tion and reactive oxygen species (ROS) were shown to up-regulate
VDAC1 expression [46,47]. Importantly, the causal relationship between
VDAC1 levels and drug sensitivity was emphasized in several studies.
Prostate cancer cell lines that were relatively resistant to apoptosis
induction by oblimersen sodium (G3139) were found to express
lower levels of VDAC1 than G3139-sensitive prostate cancer cells [48].
The anti-cancer activity of furanonaphthoquinones was increased
upon VDAC1 over-expression and decreased upon silencing of VDAC1
expression [49,50]. Recently, it was also shown that over-expression
of VDAC1 sensitized carcinoma cells to apoptosis induced by cisplatin,
mechlorethamine, and its derivative, melphalan [51]. Thus, VDAC1
over-expression following apoptosis induction by various agents, as
well as the correlation between drug efﬁcacy and VDAC1 expression
level, suggests that the activity of numerous anti-cancer drugs and
treatments is mediated via regulating VDAC1 expression levels.
Ca2+ has been shown to regulate gene transcription, with several
steps in the process of activity-dependent gene expression being
Ca2+-dependent [52,53]. As Ca2+ enhances gene expression by
inducing different nuclear events according to the nature of the
Ca2+-activated transcription factor involved [54], apoptosis stimuli
may increase VDAC1 expression levels by regulating [Ca2+]i. Here,
we report that Ca2+ plays a major role in promoting the expression
of VDAC1, thereby serving as an important mediator of VDAC1-
dependent apoptotic cell death. We further show that many pro-
apoptotic agents and stimuli, including several anti-cancer drugs,
increase [Ca2+]i and promote VDAC1 over-expression and oligomer-
ization. Based on these ﬁndings, we propose a new concept accord-
ing to which several apoptosis-inducing agents and conditions act
by up-regulating VDAC1 expression in a Ca2+-dependent manner,
leading to VDAC1 assembly into high oligomeric structures that
mediate Cyto c release and subsequent cell death.
2. Materials and methods
2.1. Materials
A23187, acridine orange, arsenic (III) oxide (As2O3), dimethyl
sulfoxide (DMSO), etoposide, ethidium bromide, hepes, hydrazine,ionomycin, lactic acid, leupeptin, nicotinamide adenine dinucleotide
(NAD+), phenylmethylsulfonyl ﬂuoride (PMSF), propidium iodide,
thapsigargin (TG) and Tris were purchased from Sigma (St. Louis,
MO). Ethylene glycolbis (succinimidylsuccinate) (EGS) was obtained
from Pierce. Rabbit monoclonal antibodies against VDAC1 (ab154856)
and Cy-2-conjugated anti-mouse antibodies came from Abcam
(Cambridge, UK). Monoclonal antibodies against actin were obtained
from Millipore (Billerica, MA) and anti-Cyto c antibodies (556432 and
556433) were obtained from BD Bioscience (San Jose, CA). Horseradish
peroxidase (HRP)-conjugated anti-mouse and anti-rabbit antibodies
were obtained from Promega (Madison, WI). Annexin V (FITC) was
from Enzo Life Sciences (Lausen, Switzerland), BAPTA-AMwas obtained
from Tocris Bioscience (Bristol, UK), while Fluo-4-AM came from
Invitrogene (Grand Island, NY). Hank's balanced salts solution (HBSS)
without calcium,magnesiumor phenol red, Dulbecco'smodiﬁed Eagle's
medium (DMEM) growth media, and the supplements fetal calf serum
(FCS), L-glutamine and penicillin-streptomycin were all obtained from
Biological Industries (Beit Haemek, Israel).
2.2. Cell lines and transfection
HeLa (human cervical adenocarcinoma), A549 (non-small human
lung carcinoma) and SKOV3 (human ovarian carcinoma) cells were
maintained inDMEMsupplementedwith 10% FCS, (except during treat-
ment with ionomycin (1%) and cisplatin and etoposide (no serum)),
2 mM L-glutamine, 1000 U/ml penicillin, and 1 μg/ml streptomycin
and maintained in a humidiﬁed atmosphere at 37 °C with 5% CO2.
2.3. Cell transfection with VDAC1
A549 cells were transiently transfected with plasmid pcDNA4/TO
(1–2 μg DNA) encoding native rVDAC1, using the JetPRIME transfection
agent (Illkirch, France) according to the manufacturer's instructions.
2.4. Cellular Ca2+ imaging and analysis
Fluo-4-AM was used to monitor changes in cytosolic Ca2+ levels.
HeLa cells (6 × 105 cells/ml) were harvested after the appropriate
treatment, collected (1500 ×g for 10 min), washed with HBSS
buffer (5.33 mM KCl, 0.44 mM KH2PO4, 138 mM NaCl, 4 mM NaHCO3,
0.3 mMNa2HPO4, 5.6 mM glucose, 0.03 mM phenol red) supplemented
with 1.8 mMCaCl2 (HBSS(+)) and incubated with 2.5 μMFluo-4 in 200
μl HBSS(+) buffer for 30 min at 37 °C and protected from light. After
washing the remaining dye, the cells were incubated with 200 μl
HBSS(+) buffer and changes in the cellular free Ca2+ concentration
were measured immediately by ﬂow cytometer analysis. At least
10,000 events were recorded on the FL1 detector, represented as a
histogram, and analyzed by the FACSCalibur ﬂow cytometer software
(BD Biosciences, Franklin Lakes, NJ). Positive cells showed a shift to an
enhanced level of green ﬂuorescence (FL1). Changes in cellular Ca2+
were monitored in live cells using the high content Operetta screening
system (Perkin–Elmer, Hamburg, Germany). In each well, ten ﬁelds
were imaged using a 20× wide ﬁeld objective, a 520–550 nm excitation
ﬁlter and a 560–630 nm emission ﬁlter.
2.5. Chemical cross-linking
HeLa cells were harvested after the appropriate treatment and incu-
bated (1.5 to 3 mg/ml) in PBS, pH 8.2) with the cross-linking reagent
EGS (150–300 μM) for 15min at 30 °C. Samples (60 to 90 μg)were sub-
jected to SDS-PAGE and immunoblotting using anti-VDAC1 antibodies,
as described below. Quantitative analysis of immuno-reactive VDAC1
dimer bands was performed using Image Gauge software (version 4.0;
Science Lab 2001) provided by Fujiﬁlm.
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Following treatment with the indicated reagents, HeLa cells (2 ×
105) were analyzed for apoptotic cell death upon staining with
propidium iodide (PI) and annexin V-ﬂuorescein isothiocyanate
(FITC), followed by ﬂow cytometer analysis. Cells were collected
(1500 ×g for 10 min), washed, and resuspended in 200 μl binding
buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM
CaCl2). Annexin V–FITC was added according to the recommended
protocol, and the cells were incubated for 15 min, protected from
light. Cells were then washed once with binding buffer and resuspend-
ed in 200 μl binding buffer, to which PI was added immediately before
ﬂow cytometry measurements. At least 10,000 events were collected,
recorded on a dot plot, and analyzed by FACSCalibur ﬂow cytometer
software. Apoptotic cell death was also visualized by acridine orange
and ethidium bromide staining as described previously [55].
2.7. Cytochrome c release
A549 cells were seeded on coverslips and were transfected 24 h
later with an empty or rVDAC1-encoding plasmid (2 μg). 48 h post-
transfection, cells were paraformaldehyde-ﬁxed (4%, 15 min), incubat-
ed for 1 hwith blocking solution (5% normal goat serum (NGS) and 0.1%
Triton X-100 in PBS) and incubated with anti-Cyto c (1:300, Cat no.
556432, BD Bioscience) antibodies for 1 h. After washing with PBS, the
cells were incubated for 1 h with Cy2-conjugated antibodies (1:300)
and washed with PBS. To stain nuclei, cells were incubated with DAPI
for 5 min at room temperature and washed with PBS. Coverslips were
mounted on glass slides with mounting medium and sealed with nail
polish. Cells were visualized by confocal microscopy.
For Cyto c release analysis by immunoblot, cells were harvested,
washed twice with PBS and gently resuspended at a concentration
of 6 mg/ml in ice-cold buffer (100 mM KCl, 2.5 mMMgCl2, 250 mM
sucrose, 20 mM HEPES/KOH pH 7.5, 0.2 mM EDTA, 1 mM dithio-
threitol, 1 μg/ml leupeptin, 5 μg/ml cytochalasin B and 0.1 mM
phenylmethylsulfonylﬂuoride) containing 0.03% digitonin and incubated
10 min on ice. Samples were centrifuged at 10,000 ×g at 4 °C for 5 min
to obtain supernatants corresponding to cytosolic extracts free of mito-
chondria and pellets corresponding to a fraction that contains mitochon-
dria. Equivalent amounts of supernatants and pellets were analyzed by
SDS-PAGE and immuno-probed using anti-Cyto c antibodies (1:2000,
Cat no. 556433, BD Bioscience).
2.8. Gel electrophoresis and immunoblotting
SDS-PAGE was performed according to the Laemmli method [56].
Gelswere electro-transferred onto nitrocellulosemembranes for immu-
nostaining. Membranes containing the transferred proteins were
blocked with 5% non-fat dry milk and 0.1% Tween-20 in Tris-buffered
saline and incubated withmonoclonal anti-VDAC1 antibodies, followed
by incubationwith HRP-conjugated anti-mouse IgG secondary antibod-
ies. After treatment with the appropriate primary and secondary anti-
bodies, bands were visualized using an enhanced chemiluminescence
kit (Biological Industries). For VDAC1 over-expression and cross-
linked product analysis, 15–30 μg protein of cell lysate was subjected
to SDS-PAGE and immunoblotting using anti-VDAC1 antibodies. Quan-
titative analysis of immuno-reactive VDAC1 bands was performed
using Image Gauge software (version 4.0; Science Lab 2001), provided
by Fujiﬁlm.
2.9. Quantiﬁcation of hydrogen peroxide
HeLa cells were incubated with hydrogen peroxide (0.8 mM) and at
different time points (0–4 h), aliquots of themediumwere analyzed for
H2O2 levels by spectrophotometric measurement at 454 nm, using the
vanadium pentoxide/sulfuric acid method [57].2.10. Lactate dehydrogenase levels
HeLa cells were treated as described above and aliquots of the
culture medium and total cell lysates were analyzed for lactate dehy-
drogenase (LDH) activity by monitoring NADH reduction at 340 nm.
The assay buffer contained (ﬁnal concentrations) glycine 160 mM,
hydrazine 160 mM, NAD+ 0.29 mM, lactate 5 mM and equivalent
amounts ofmediumor cell lysates. Rates of LDH activity weremeasured
at 340 nm using a plate reader.
3. Results
3.1. Apoptosis stimuli increase VDAC1 expression levels
To test our hypothesis that apoptosis stimuli act via enhancing
VDAC1 expression, leading to VDAC1 oligomerization and apoptosis,
we evaluated the effects of four different apoptosis inducers on VDAC1
expression levels (Fig. 1A). The effects of As2O3, etoposide, cisplatin
and H2O2 on VDAC1 expression were analyzed in HeLa (human cervical
cancer), SKOV-3 (human ovarian carcinoma) and A549 (human lung
adenocarcinoma alveolar basal epithelium) cells following their incuba-
tion with escalating concentrations of these reagents. All apoptosis
inducers increased the VDAC1 expression level in each of the three
cell lines tested in a concentration-dependent manner, as monitored
by immunoblotting (Fig. 1A). Drug-induced VDAC1 over-expression
was time-dependent, with the time for maximal increase in VDAC1
level (1–16 h) being dependent on the reagent used and its concen-
tration (Fig. 1B). Speciﬁcally, VDAC1 expression was increased by
over 4-fold, depending on the agent concentration and the cell type
tested (Fig. 1C).
As these apoptosis agents are also known to disrupt Ca2+ homeosta-
sis, we analyzed whether they also elevated cytosolic Ca2+ levels
under those conditions leading to VDAC1 over-expression (Fig. 1D).
Incubation of HeLa cells with H2O2, cisplatin, etoposide or As2O3 resulted
in elevated [Ca2+]i levels, as visualized by Fluo-4 ﬂuorescence and
monitored by cell imaging with the Operetta system (Fig. 1D). Together,
these results indicate that different apoptosis-inducing compounds,
regardless of their mechanism of action, elevated intracellular Ca2+
levels and induced VDAC1 over-expression.
3.2. Apoptosis inducers lead to VDAC1 over-expression, intra-cellular
[Ca2+] elevation, VDAC1 oligomerization and apoptosis
Next, we examined the relationship between VDAC1 over-expression,
elevation of [Ca2+]i, VDAC1 oligomerization, and apoptosis induction
(Fig. 2). As2O3 induced VDAC1 over-expression (Fig. 2A) and VDAC1
oligomerization (Fig. 2B) in a concentration-dependent manner, as
revealed using chemical cross-linking with EGS and Western blotting
with anti-VDAC1 antibodies. Several anti-VDAC1 antibody-labeled protein
bands corresponding to VDAC1 dimers, trimers, tetramers andmultimers
were obtained upon exposure to As2O3. In addition, monomeric VDAC1
with higher mobility was obtained upon apoptosis induction and EGS
treatment (asterisk in Fig. 2B), representing a monomer that underwent
conformational changes that were ﬁxed upon inter-molecular cross-
linking, thereby modifying its mobility in SDS-PAGE. In parallel to the
increase in VDAC1 expression, elevation of [Ca2+]i (Fig. 2C) and apoptotic
cell death as analyzed by annexin V–FITC and PI staining followed byﬂow
cytometer analysis, were also obtained (Fig. 2D). All these parameters
were similarly increased as a function of As2O3 concentration (Fig. 2E),
suggesting association between VDAC1 over-expression, increased
cytosolic Ca2+, VDAC1 oligomerization and apoptosis.
Next, to verify the sequence of events, we analyzed the time course
of the increase in VDAC1 expression (Fig. 3A and C), VDAC1 oligomeri-
zation (Fig. 3B and C), elevation in [Ca2+]i levels and apoptosis, all as in-
duced by H2O2 (Fig. 3C). The results show that the increase in [Ca2+]i
induced by H2O2 is transient and proceeds enhanced VDAC1 over-
Fig. 1. Apoptosis inducers up-regulate VDAC1 expression and elevated cytosolic Ca2+. (A) SKOV-3, A549 and HeLa cells were incubated with the indicated concentrations of cisplatin
(24 h), H2O2 (6 h), etoposide (24 h) or As2O3 (12 h). VDAC1 expression levels were analyzed by immunoblotting followed by quantitative analysis of VDAC1 expression presented in
the bottom of each blot as fold increase. (B) For the time course of selenite (8 μM)-, H2O2 (0.5 mM)- and As2O3 (20 μM)-induced VDAC1 over-expression, HeLa cells were incubated
with the indicated reagent for the indicated time and the VDAC1 expression level was analyzed as in A. (C) The increase in VDAC1 levels obtained in the HeLa (grey bars), SKOV-3
(black bars) and A549 (dark grey bars) cells following treatment with H2O2 (0.4, 0.5, 1 mM, for SKOV-3, HeLa and A549, respectively), As2O3 (20, 20, 120 μM, for HeLa, SKOV-3 and
A549, respectively), cisplatin (20 μM) or etopoide (60 μM) is presented. (D) For analysis of changes in cytosolic Ca2+ upon apoptosis induction, HeLa cells were plated on black CellCarrier
96-well plates overnight and then treated for 8 h with As2O3 (10 μM), etoposide (10 μM), cisplatin (25 μM), As2O3 (10 μM) or H2O2 (0.5mM for 6 h), followed by incubation with Fluo-4.
Cell ﬂuorescence was recorded using the Operetta. The results shown correspond to either the mean ± SD or a representative of 2–3 similar experiments, as appropriate.
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analyzing the concentration of H2O2 in the medium as function of
time, it was clear that H2O2 concentration decreased with time with a
similar time course as the decrease in [Ca2+]i (Fig. 3C). A correlation be-
tween the increase in VDAC1 expression level, VDAC1 oligomerization
and apoptosis was observed, suggesting a strong association between
the three processes that followed the increase in cytosolic [Ca2+]i. The
H2O2-induced elevation in [Ca2+]i is required for enhanced VDAC1
expression, oligomerization and apoptosis, as all were inhibited by
BAPTA (see Fig. 5).
3.3. Increased intracellular Ca2+ encodes information that up-regulates
VDAC1 expression
Next, to test the direct effect of elevating [Ca2+]i on the levels of
VDAC1 expression and oligomerization, we employed Ca2+-mobilizingagents, namely the ionophores ionomycin and A23187 and the inhibitor
of the Ca2+ pump SERCA (sarco/endoplasmic reticulum calcium-
ATPase), thapsigargin. All allowed for an increase in [Ca2+]i in both cyto-
sol and mitochondria. Incubation of HeLa cells with these [Ca2+]i level-
elevating reagents resulted in a several-fold increase inVDAC1 expression
levels, in a concentration-dependent manner (Fig. 4A), and as expected,
increased [Ca+]i (Fig. 4B). Cells treated with thapsigargin or A23187
showed intense punctuated Fluo-4 ﬂuorescence, which may represent
Ca2+ accumulated in themitochondria or in other intracellular organelles
(Fig. 4B, arrows). Incubation of cells with ionomycin also resulted in a
marked increase in VDAC1 over-expression (Fig. 4C) and oligomerization
(Fig. 4D), aswell as in apoptotic cell death, as analyzed by annexin V–FITC
and PI staining (Fig. 4E) and as visualized upon staining with acridine or-
ange/ethidium bromide (Fig. 4F). As expected, ionomycin increased
[Ca2+]i levels, as monitored using Fluo-4 and ﬂow cytometer analysis,
at all tested concentrations, except at the highest concentration used,
Fig. 2. As2O3 elevates interacellular Ca2+ levels, up-regulates VDAC1 expression and induces VDAC1 oligomerization and apoptosis. HeLa cells were incubated (14 h)with various concen-
trations of As2O3, harvested and VDAC1 expression (A), VDAC1 oligomerization (B), intracellular Ca2+ levels (C) and apoptotic cell death (D) were analyzed. VDAC1 oligomerization was
revealed using EGS-based cross-linking. Cells (2.5 mg/ml) were washed with PBS, pH 8.3 and incubated with EGS (250 μM) at 30 °C for 15 min and then subjected to SDS-PAGE and im-
munoblotting using anti-VDAC1 antibodies. The positions of VDAC1monomers tomultimers are indicated. (C) Representative ﬂow cytometer analysis of [Ca2+]i levels in control cells and
in cells treatedwith As2O3 (20 μM, 14 h), asmonitored using Fluo-4. The values shown indicate the increase in [Ca2+]i. (D) Apoptosiswas determined using annexin V–FITC and PI staining
and ﬂow cytometer analysis. (E) Summary of the quantitative analysis of VDAC1 expression, VDAC1 dimer and [Ca2+]i levels and apoptosis. The results shown correspond to either the
mean ± SD or a representative of 2–4 similar experiments, as appropriate.
Fig. 3.H2O2 elevates interacellular Ca2+ levels, up-regulates VDAC1 expression and induces VDAC1 oligomerization and apoptosis. HeLa cellswere incubatedwith 0.8mMH2O2, harvested
and VDAC1 expression (A), VDAC1 oligomerization (B), intracellular Ca2+ levels and apoptotic cell death (C)weremeasured as a function of incubation timewithH2O2. VDAC1 expression
levelswere analyzed by immunoblotting, using anti-VDAC1 antibodies (A). VDAC1 oligomerizationwas revealed using EGS-based cross-linking. Cells (2.5 mg/ml)werewashedwith PBS,
pH 8.3 and incubatedwith EGS (250 μM) at 30 °C for 15min and then subjected to SDS-PAGE and immunoblotting using anti-VDAC1 antibodies (B). The positions of VDAC1monomers to
multimers are indicated. Apoptotic cell death and [Ca2+]i levels were monitored as a function of time by ﬂow cytometer analysis using annexin-V FITC and propidium iodide, and Fluo-4,
respectively (C). H2O2 levels as a function of timewere analyzed and are presented as a dashed line. The results shown correspond to either themean± SD or a representative of 2 similar
experiments, as appropriate.
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Fig. 4. Increased intracellular Ca2+ induces up-regulation of VDAC1 expression that is correlatedwith increased VDAC1 oligomerization and apoptosis. (A) HeLa cells were incubatedwith
thapsigargin (10 μM, 24h), ionomycin (4 μM, 45min) or A23187 (2 μM, 24h), harvested and VDAC1 expression levelswere analyzed by immunoblotting followed by quantitative analysis
of VDAC1 expression. Relative amounts (RU) of VDAC1 expression are given at the bottom. (B) For monitoring [Ca2+]i levels, HeLa cells were seeded on black CellCarrier 96-well plates
overnight and then treated as described in (A), followed by incubation with Fluo-4. Cell ﬂuorescence was recorded using the Operetta. Representative images are shown. (C,D) HeLa cells
were incubatedwith the indicated concentrations of ionomycin (1–5 μM, 45 min), followed by analysis of VDAC1 expression levels (C) and oligomerization (D). Apoptotic cell death was
analyzed using annexin-V FITC/propidium iodide staining and ﬂow cytometer analysis (E) and acridine orange/ethidium bromide staining (F). In F, arrows indicate cells at an early apo-
ptotic state, reﬂected by degraded nuclei (stained with acridine orange) andmembrane blebbing. Arrowheads indicate cells in the late apoptotic state (stained with both acridine orange
and ethidiumbromide, orange color). (G) Quantitative analysis of VDAC1 expression levels (C) and oligomerization (D), apoptotic cell death (E), aswell as of [Ca2+]i levels, as determined
by Fluo-4 andﬂow cytometer analysis is presented in (G) as function of ionomycin concentration. The results shown correspond to either themean±SD or a representative of 2–4 similar
experiments, as appropriate. LDH levels in the medium from control and ionomycin-treated cells were analyzed as described in the Methods section (Fig. 4H). The total cellular LDH in
control cells is considered as 100%.
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cell death (Fig. 4E).
Several studies, particularly those involving cardiomyocytes or
neurons, suggest that A23187 induces the necrotic form of cell death
[58,59]. Yet, A23187 was shown to induce a rise in cytoplasmic Ca2+
at both early and late stages of the apoptotic process [60] and to inducemitochondria-associated apoptotic events [61]. Similarly, ionomycin
was also shown to induce either necrosis or apoptosis [62,63]. Thus,
although our results (Fig. 4E and F) clearly indicate that ionomycin
induced apoptotic cell death, we tested whether under the conditions
used it also caused necrosis. Release of LDH to themedium is considered
to be a necrotic event. Therefore, the level of LDH in the medium from
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dicate that under the condition used, the level of LDH in the medium
was increased, although this activity represents only 20–40% of the
total cellular LDH activity (Fig. 4H). It should be noted, however, that
LDH release may reﬂect primary necrosis but also secondary necrosis
as a consequence of apoptotic cell death (see [64]).
The integrated results (Fig. 4G) indicate that the increase in [Ca2+]i
precedes VDAC1 over-expression and oligomerization and apoptosis,
with all showing similar augmentation as a function of ionomycin
concentration. These results suggest that the increase in [Ca2+]i is pre-
requisite for activation of the other tested processes, and demonstrate
that strong association exists between the increase in [Ca2+]i, VDAC1
expression levels, VDAC1 oligomerization and apoptosis.
3.4. Ca2+ is required for pro-apoptotic agent-induced VDAC1
over-expression, VDAC1 oligomerization and apoptosis
To assess the requirement of Ca2+ for VDAC1 over-expression,
VDAC1 oligomerization and apoptosis induction, the effects of the cell-
permeable Ca2+ chelating reagent BAPTA-AM (acetoxymethyl ester
form of bis(aminophenoxy)ethan -N,N,N′,N′-tetraacetic acid) on these
processes were evaluated. Pre-incubation of HeLa or A549 cells with
BAPTA-AM resulted in prevention of cisplatin- (data not shown),
H2O2- and As2O3-induced VDAC1 over-expression (Fig. 5A–F). BAPTA
also prevented the apoptotic cell death induced by H2O2 (Fig. 5D).Fig. 5.Up-regulation of VDAC1 expression induced by H2O2 or As2O3 is inhibited by BAPTA-AM
and then without or with the indicated concentrations of H2O2 (A, B, 5 h) or As2O3, (E,
(A, C, E). Quantitative analysis of VDAC1 expression levels of HeLa cells treatedwith As2O3 (20 μ
is presented. (o) Indicates untreated cells. The effect of BAPTA-AM on apoptosis induced by H2
results shown correspond to either the mean ± SD or a representative of 2–4 similar experimThe relationship between the effects of BAPTAonVDAC1 expression,
VDAC1 oligomerization and apoptotic cell death was studied by
monitoring these activities in parallel, as all induced by As2O3 (Fig. 6).
Apoptotic cell death (Fig. 6A), VDAC1 over-expression (Fig. 6B) and
VDAC1 oligomerization (Fig. 6C) were all strongly inhibited by BAPTA-
AMwith a clear association between these activities (Fig. 6D), indicating
a major role for [Ca2+]i in inducing VDAC1 over-expression, oligomeri-
zation and apoptotic cell death.
3.5. VDAC1 over-expression-induced VDAC1 oligomerization and apoptosis
can occur with no increase in cytosolic Ca2+ levels
To demonstrate that increased VDAC1 levels encourage VDAC1 olig-
omerization and apoptosis, as well as the requirement for [Ca2+]i when
VDAC1 is over-expressed, cells were transfected to over-express VDAC1
and the above activities were analyzed (Fig. 7). Cells transfected with
empty or VDAC1-expressing vectors were subjected to cross-linking
with different EGS concentrations and the formation of VDAC1
homo-oligomers, comprising dimers to higher molecular mass
complexes, was analyzed and found to be highly enhanced in cells
over-expressing VDAC1 (Fig. 7A). Almost no oligomerization was
observed in control cells, unless apoptosis was induced, such as with
H2O2 (Fig. 7B). In VDAC1-over-expressing cells, the concentration
of EGS required to attain 50% of the maximal level of dimers (or oligo-
mers) was over 16-fold lower than in H2O2-treated cells, respectively. HeLa or A549 cells were incubated with the indicated concentration of BAPTA-AM for 1 h
F, 12 h), harvested, and VDAC1 expression levels were analyzed by immunoblotting
M, 12 h,Δ) (B) orwith H2O2 (1.5mM, 5 h,Δ) (F), as a function of BAPTA-AMconcentration
O2 was analyzed using annexin V–FITC and PI staining, followed by FACS analysis (D). The
ents, as appropriate.
Fig. 6. BAPTA-AM prevents VDAC1 over-expression, VDAC1 oligomerization and apoptotic cell death induced by As2O3. HeLa cells were incubated with BAPTA-AM (20 μM, 1 h) and then
with or without As2O3 (5–20 μM, 14 h). Cells were harvested, cross-linked with EGS (250 μM, 15 min), and analyzed by immunoblotting using anti-VDAC1 antibodies for VDAC1 expres-
sion levels (A), VDAC1 oligomerization (B) and apoptotic cell death (C), as described in the legend to Fig. 2. Results are representative of 2–3 similar experiments. Quantitative analysis of
VDAC1 over-expression (▲,Δ) and VDAC1 oligomerization (dimers) (■,□) and apoptosis (●,○), with the empty symbols representing the presence of BAPTA, are presented as a function
of As2O3 concentration (D) (n= 2–3).
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equilibrium shifted from themonomeric to the oligomeric state, leading
to Cyto c release as analyzed by both immunocytochemistry and immu-
noblotting (Fig. 7E and F). Indeed, as reported previously [34,65–69],
cells over-expressing VDAC1 underwent apoptotic cell death, as visual-
ized upon staining with acridine orange/ethidium bromide (Fig. 7G).
These cells showed membrane blebbing, chromatin condensation and
orange-staining, reﬂecting a late apoptotic stage. The apoptotic cell
death induced by VDAC1 over-expression was also analyzed by
Annexin V/PI staining (Fig. 7H).
To verify whether an increase in [Ca2+]i is required for apoptosis in-
ductionwhenVDAC1 is over-expressed,we analyzed changes in [Ca2+]i
and apoptosis and the effects of BAPTA-AM on both parameters in cells
over-expressing VDAC1. Upon VDAC1 over-expression (Fig. 7D), about
50% of the cells underwent apoptosis, as analyzed byAnnexin V/PI stain-
ing (Fig. 7H). In contrast, no change in the [Ca2+]i level was observed
(Fig. 7H), with BAPTA-AM having no effect on apoptosis as induced by
VDAC1 over-expression, as opposed to the inhibition of As2O3- or
H2O2-induced apoptosis (Figs. 5 and 6). These ﬁndings suggest that
changes in [Ca2+]i levels are not pre-requisite for apoptosis induction
when VDAC1 is over-expressed.
4. Discussion
4.1. Apoptosis inducers induce VDAC1 over-expression and increase
intracellular Ca2+ levels
While acceptedmodes of actions have been described for the ma-
jority of apoptosis inducers, various studies indicate that most of
these agents act via multiple pathways. In the present report, an ad-
ditional mode of action for apoptosis stimulus involving increased
expression of VDAC1 is proposed. Indeed, several cancer treatments
and apoptosis inducers were found to increase VDAC1 expression
levels [41–45,47]. We further argue that apoptosis-inducing agents
act by increasing [Ca2+]i and that this in turn leads to an up-regulation of VDAC1 expression. This is followed by VDAC1
oligomerization, Cyto c release and, ﬁnally, cell death (Fig. 8B).
Hence, based on our ﬁndings, we offer a new view of the mechanism
of apoptosis induction by chemotherapeutic agents and other
apoptosis-inducing treatments.
Although the novel mechanism we propose, whereby apoptosis in-
ducers act by initially increasing VDAC1 expression, is supported by
the results presented in this study (Figs. 1–7), previously published
ﬁndings also can be explained by themode of actionwepropose. For ex-
ample, the commonly accepted mechanism of cisplatin action involves
the cross-linking of nuclear DNA [70]. However, cisplatin-mediated
cell death was also proposed to involve mitochondria dysfunction and
VDAC1 [71,72]. Here we have shown that cisplatin induces over-
expression of VDAC1 in the three cell lines tested (Fig. 1). Likewise, cis-
platin was shown to induce VDAC1 over-expression in a cisplatin-
sensitive cervix squamous cell carcinoma cell line (A431) but not in a
cisplatin-resistant cell line (A431/Pt) [42]. The requirement of VDAC1
for cisplatin-induced cell death is also reﬂected in the inhibition of
cisplatin-induced apoptosis and Bax activation in non-small cell lung
cancer when the VDAC1 expression level was reduced by siRNA [73].
Similarly, etoposide, targeting DNA topoisomerase II [74], was found
to affect cell metabolism and gene expression at different levels [75].
Here, we have demonstrated that etoposide induces VDAC1 over-
expression (Fig. 1). In the case of H2O2, induction of apoptosis was
proposed to occur via oxidative stress [76]. In the present study, we
ﬁnd that H2O2 also induced VDAC1 over-expression (Figs. 1, 3 and 7).
Indeed, ROS were previously shown to induce VDAC1 up-regulation in
a manner that was prevented by the ROS chelator epigallocatechin
[46]. Finally, selenite was proposed to induced cell death via multiple
modes of action [77,78], albeit via poorly deﬁned mechanism(s) [78,
79]. Here, we showed that selenite induced VDAC1 over-expression
(Fig. 1B). The decrease in selenite-induced apoptosis seen upon silenc-
ing VDAC1 expression [78] suggests that VDAC1 is involved in the
mode of action of this compound. Interestingly, selenite was found to
induce Bax over-expression [80]. This, with the increase in VDAC1
Fig. 7.VDAC1 over-expression results inVDAC1 oligomerization and apoptosis,without affecting cytosolic Ca2+ levels. In (A), A549 cellswere transfectedwith an empty vector or rVDAC1-
encoding pcDNA 4/To (2 μg of DNA). After 48 h, the cells were harvested and subjected to cross-linking with the indicated EGS concentration, followed by immunostaining using anti-
VDAC1 antibodies. In (B), cells were exposed to H2O2 (0.8 mM, 6 h) and then subjected to cross-linking with the indicated concentration of EGS. Quantitative analysis of VDAC1 dimer
formation in cells transfected with the empty plasmid, control (□), over-expressing rVDAC1 (●) or exposed to H2O2 (■) is presented as a function of EGS concentration (C). A represen-
tative of three similar experiments is shown. For the assayof apoptosis andCyto c release, cellswere transfectedwith an empty vector or rVDAC1-encodingpcDNA4/To (as indicated, 1 or 2
μg of DNA) and sampleswere analyzed for VDAC1 expression levels (D), Cyto c release (E, F), as analyzed by immunoblotting or immunocytochemical staining using anti-Cyto c antibodies
(scale bars, 10 μm) or for apoptotic cell death, visualized by acridine orange and ethidiumbromide staining (G). In G, arrows indicate cells at an early apoptotic state, reﬂected by degraded
nuclei (stained with acridine orange) and membrane blebbing. Arrowheads indicate cells in the late apoptotic state (stained with both acridine orange and ethidium bromide, orange
color). Scale bars, 30 μm. In F, about 70% of the cells showed diffused and weak ﬂuorescence representing Cyto c released from the mitochondria. In H, cells were transfected with the
empty vector or rVDAC1-encoding pcDNA 4/To (2 μg of DNA) and 48 h post-transfection, the cells were incubated with or without BAPTA-AM (20 μM, 12 h) and analyzed for apoptotic
cell death using Annexin V/PI staining (grey bars). Changes in Ca2+ levels weremonitored using Fluo-4 and ﬂow cytometer analysis (black bars). The results shown correspond to either
the mean ± SD or a representative of 2–4 similar experiments, as appropriate.
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expression levels.
In summary, although these different apoptosis inducers elicit cell
death via different mechanisms, the present study shows that all not
only induce VDAC1 over-expression but also increase [Ca2+]i levels
(Figs. 1–6). Thus, it is possible that elevating [Ca2+]i represents a com-
mon mechanism for the various apoptosis stimuli considered here,and that elevated [Ca2+]i leads to elevation in VDAC1 expression levels.
Indeed, Ca2+ was found to be essential for VDAC1 over-expression,
since BAPTA-AM, which abrogates intracellular Ca2+ levels, signiﬁcant-
ly decreased VDAC1 over-expression as induced by various agents
(Figs. 5 and 6). Furthermore, the direct increase in [Ca2+]i generated
by the Ca2+ ionophores A23187, ionomycin or thapsigargin induced
VDAC1 over-expression (Fig. 4). These ﬁndings suggest that Ca2+
Fig. 8. Proposedmodel for the role of increasing [Ca2+]i in VDAC1 expression and subsequent cell death induction. Themodel presented in (A) suggests that apoptosis induction by a given
stimuli causes an increase in intracellular Ca2+ levels, leading to enhanced VDAC1 expression,most probably activating the VDAC1 promoter directly or by stimulating the activity of tran-
scription factors. The increase in VDAC1 expression shifts the equilibrium towards the VDAC1 oligomeric state, allowing for Cyto c release from the inner mitochondria space, leading to
apoptotic cell death. When VDAC1 is over-expressed by transfection, no change in the intracellular Ca2+ level was observed (Fig. 7G), suggesting that Ca2+ is required for induction of
VDAC1 over-expression and not for the subsequent steps leading to VDAC1 oligomerization, Cyto c release and ﬁnally, apoptotic cell death (B).
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enhanced VDAC1 expression being subsequently associated with an
induction of cell death (Fig. 8).
4.2. Apoptosis-activating stimuli act by inducing VDAC1 over-expression:
a proposed mechanism
The cellular expression level of VDAC1 is a crucial factor for the
process of mitochondria-mediated apoptosis. As presented here
(Fig. 7) and in previous studies [34,65–69], exogenous over-
expression of VDAC1 results in cell death, regardless of the cell type con-
sidered or the origin of VDAC used [34,67–69]. Cell death, as induced by
exogenous VDAC1 over-expression, presents the classical hallmarks of
apoptosis, including those morphologic changes associated with apo-
ptosis, such as cell shrinkage, membrane blebbing, phosphatidylserine
surface exposure, and nuclear condensation and fragmentation, as
well as release of Cyto c (Fig. 7). Such cell death can be blocked by HK
[34] or DIDS [68], both shown to interact with VDAC1 [32,81].
It was shown previously [16,27,37–39] and here (Fig. 7) that over-
expression of VDAC1 dramatically enhanced VDAC1 oligomerization
and apoptosis in the absence of any apoptotic stimuli. These reports
further argued that VDAC1 oligomerization is involved in the release
of Cyto c from mitochondria, thereby contributing to subsequent cell
death [37,38].
In the present study, we demonstrated the tight correlation that
exists between the increase in VDAC1 expression levels, VDAC1
oligomerization and apoptosis (Figs. 2–6). This is further reﬂected in
the constant VDAC1 monomer to dimer ratio of 2.3 to 2.6 obtained
when apoptosis was induced chemically or upon VDAC1 over-
expression (Figs. 2–7). Accordingly, we suggest that apoptotic stimuli
act by inducing VDAC1 over-expression, leading to the increased forma-
tion of VDAC1 oligomers mediating Cyto c release, and as such, apopto-
sis (Fig. 8).
We further propose that changes in [Ca2+]i provide the link
between the actions of apoptosis inducers and the elevation of VDAC1
expression levels. Accumulated evidence has demonstrated the impor-
tance of Ca2+ in the activation and execution of cell death [5–7,82].
Indeed, [Ca2+]i increases have been observed during apoptotic cell
death [5–7,82] and have been shown to be required for apoptosis to
transpire [6,7,83]. We have now shown that VDAC1 over-expression,
VDAC1 oligomerization and apoptosis, as induced by various apoptosis
stimuli, are not only all associated with an increase in [Ca2+]i
(Figs. 1–3) but can also be induced by a direct increase in [Ca2+]i
(Fig. 4). On the other hand, the same events are blocked by BAPTA,
again suggesting a link between the increase in [Ca2+]i, VDAC1 over-
expression, VDAC1 oligomerization and apoptotic cell death. While
the sequence of these events was not fully resolved in this study, thepresented results indicate that the increase in [Ca2+]i occurs prior to
VDAC1 over-expression, VDAC1 oligomerization or apoptosis induction
(Figs. 3–6). The proposed order of reactions is presented in Fig. 8. Still,
while Ca2+ is required for drug-induced VDAC1 over-expression and
apoptosis induction (Figs. 5 and 6), it is not required for apoptosis as
induced by plasmid-mediated VDAC1 over-expression, as no increase
[Ca2+]i was observed, and BAPTA did not prevent such apoptotic cell
death (Fig. 7). This suggests that under the conditions used here,
[Ca2+]i is required for inducing VDAC1 over-expression but not for
the subsequent steps leading to apoptosis (Fig. 8B).
Several potential Ca2+-dependent steps could contribute to the en-
hanced expression of proteins. These steps includemRNA transcription,
elongation, splicing, stability, and/or translation [84–86]. In addition,
Ca2+-responsive elements (CaRE) or Ca2+-dependent transcription
factors could be involved, as could be the activation of calcineurin,
leading to the expression of hypertrophic response genes [87–89], or
Ca2+-mediated activation of promoter-bound transcription factor com-
plexes [90]. The mechanism(s) by which Ca2+ induces VDAC1 over-
expression could be at the transcriptional level, via Ca2+-dependent
transcription factors or by othermechanisms. This suggestion, however,
does not rule out the possibility that Ca2+ assumes other roles in cell
death, as induced by apoptosis stimuli.
In conclusion, the ﬁndings presented in this study, together with the
observed induction of VDAC1over-expressionby various drugs [41–47],
offer support for a new mechanism of pro-apoptotic drug action,
namely enhancement of VDAC1 expression. Further study of this
novel mechanism may thus provide a platform for developing a new
class of anti-cancer drugs.Acknowledgments
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